Latest News and Press Releases
Want to stay updated on the latest news?
-
Compass Therapeutics announces 2nd quarter results and provides clinical results update
-
Initiated patient enrollment in a U.S. Phase 2/3 study of CTX-009 (DLL4 /VEGF-A bispecific antibody) in patients with advanced biliary tract cancers (BTC). Top line data is expected in the first half...